Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123M Buy
489,495
+4,215
+0.9% +$907K 1.4% 13
2026
Q1
$106M Buy
485,280
+3,331
+0.7% +$739K 1.32% 13
2025
Q4
$110M Buy
481,949
+1,853
+0.4% +$422K 1.37% 11
2025
Q3
$111M Buy
480,096
+371
+0.1% +$75.5K 1.45% 10
2025
Q2
$89M Buy
+479,725
New +$89.2M 1.23% 12

Other funds holding ABBV

Midwest Trust's ABBV Position: Q2 2026 in Review

Midwest Trust increased its AbbVie (ABBV) stake by 0.87% in Q2 2026, buying an estimated $907K and bringing the position to 489,495 shares worth $123M. The position accounts for 1.4% of the portfolio, ranked #13.

Midwest Trust first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Midwest Trust held 489,495 shares of AbbVie worth $123M as of Q2 2026.
  • Midwest Trust bought 4,215 AbbVie shares in Q2 2026, an estimated $907K.
  • AbbVie made up 1.4% of Midwest Trust's portfolio in Q2 2026, its #13 holding.
  • Midwest Trust first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.